Recent Finacing
Recent Raise
Corthera develops Relaxin, a hormone therapeutic to reduce pulmonary fluid congestion and hypertension in heart failure, showing phase II improvements in patient breathlessness and advancing toward phase III trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors